{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:53:36Z","timestamp":1762552416450,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002640"],"award-info":[{"award-number":["82002640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018615","name":"Key University Science Research Project of Jiangsu Province","doi-asserted-by":"publisher","award":["20KJB320028"],"award-info":[{"award-number":["20KJB320028"]}],"id":[{"id":"10.13039\/501100018615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.intimp.2025.114933","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T15:17:30Z","timestamp":1748704650000},"page":"114933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-omics identifies OSM-OSMR as a key receptor-ligand in the tumor environment of endometrial adenocarcinoma"],"prefix":"10.1016","volume":"160","author":[{"given":"Qiuao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10023","key":"10.1016\/j.intimp.2025.114933_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2025.114933_bb0010","first-page":"80","article-title":"Consensus on fertility preservation treatment for early stage endometrial cancer and atypical hyperplasia","volume":"54","author":"Chen","year":"2019","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.intimp.2025.114933_bb0015","doi-asserted-by":"crossref","unstructured":"Y. Dou, K. Song, Y. Fu, Y. Shen, C. Zhang, S. Yao, C. Xu, M. Xia, G. Lou, J. Liu, B. Lin, J. Wang, W. Zhao, J. Zhang, W. Cheng, H. Guo, R. Guo, F. Xue, X. Wang, L. Han, X. Zhao, X. Li, P. Zhang, J. Zhao, J. Ma, W. Li, X. Yang, Z. Wang, J. Liu, Y. Fang, K. Li, G. Chen, C. Sun, X. Cheng, J. Jiang, B. Wang, D. Luo, B. Kong, C. Chinese Endometrial Carcinoma, Risk Factors and Prognosis of Early Recurrence in Stage I-II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study, Front Med (Lausanne) 9 (2022) 808037.","DOI":"10.3389\/fmed.2022.808037"},{"issue":"1","key":"10.1016\/j.intimp.2025.114933_bb0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41420-021-00603-z","article-title":"LIF\/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer","volume":"7","author":"Tang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.intimp.2025.114933_bb0025","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1158\/0008-5472.CAN-08-2816","article-title":"Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer","volume":"69","author":"Tomlinson","year":"2009","journal-title":"Cancer Res."},{"issue":"2 Pt 1","key":"10.1016\/j.intimp.2025.114933_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/1078-0432.459.11.2","article-title":"Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth","volume":"11","author":"Gomez-Roman","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"6973","key":"10.1016\/j.intimp.2025.114933_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature02216","article-title":"fgf8 mRNA decay establishes a gradient that couples axial elongation to patterning in the vertebrate embryo","volume":"427","author":"Dubrulle","year":"2004","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.intimp.2025.114933_bb0040","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.7150\/jca.44727","article-title":"Fibroblast growth factor receptor signaling as therapeutic targets in female reproductive system cancers","volume":"11","author":"Zhu","year":"2020","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.114933_bb0045","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/s41467-021-27607-8","article-title":"Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.intimp.2025.114933_bb0050","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-21-0483","article-title":"Oncostatin M receptor-targeted antibodies suppress STAT3 signaling and inhibit ovarian Cancer growth","volume":"81","author":"Geethadevi","year":"2021","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.intimp.2025.114933_bb0055","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1038\/onc.2012.573","article-title":"Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition","volume":"32","author":"Guo","year":"2013","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2025.114933_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/CBM-2012-00276","article-title":"Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73","volume":"11","author":"Liang","year":"2012","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.intimp.2025.114933_bb0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1476","article-title":"Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate","volume":"202","author":"Royuela","year":"2004","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114933_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pros.20235","article-title":"Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"64","author":"Godoy-Tundidor","year":"2005","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.intimp.2025.114933_bb0075","first-page":"101","article-title":"Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3","volume":"28","author":"Li","year":"2011","journal-title":"Int. J. Mol. Med."},{"issue":"2A","key":"10.1016\/j.intimp.2025.114933_bb0080","first-page":"1011","article-title":"Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor","volume":"19","author":"Mori","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2025.114933_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6653247","article-title":"A risk signature with nine Stemness index-associated genes for predicting survival of patients with uterine Corpus endometrial carcinoma","volume":"2021","author":"Xu","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.intimp.2025.114933_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.omto.2021.07.002","article-title":"Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer","volume":"22","author":"Zheng","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.intimp.2025.114933_bb0095","doi-asserted-by":"crossref","first-page":"1094042","DOI":"10.3389\/fimmu.2023.1094042","article-title":"Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114933_bb0100","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","article-title":"Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2025.114933_bb0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"issue":"4","key":"10.1016\/j.intimp.2025.114933_bb0110","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes","volume":"15","author":"Efremova","year":"2020","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.intimp.2025.114933_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.intimp.2025.114933_bb0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/biostatistics\/kxu010","article-title":"Random survival forests for competing risks","volume":"15","author":"Ishwaran","year":"2014","journal-title":"Biostatistics"},{"key":"10.1016\/j.intimp.2025.114933_bb0125","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2025.114933_bb0130","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114933_bb0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0704769","article-title":"Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts","volume":"136","author":"Scaffidi","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114933_bb0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s13167-023-00327-3","article-title":"Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework","volume":"14","author":"Liu","year":"2023","journal-title":"EPMA J."},{"issue":"2","key":"10.1016\/j.intimp.2025.114933_bb0145","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/jcmm.16188","article-title":"Expression of CAMK1 and its association with clinicopathologic characteristics in pancreatic cancer","volume":"25","author":"Lei","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"18","key":"10.1016\/j.intimp.2025.114933_bb0150","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","article-title":"Development and validation of a Radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal Cancer","volume":"34","author":"Huang","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.114933_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.885267","article-title":"Mapping and validation of scRNA-Seq-derived cell-cell communication networks in the tumor microenvironment","volume":"13","author":"Bridges","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114933_bb0160","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3389\/fimmu.2019.01165","article-title":"Oncostatin M, an underestimated player in the central nervous system","volume":"10","author":"Houben","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114933_bb0165","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1158\/1541-7786.MCR-22-0715","article-title":"Oncostatin-M and OSM-receptor feed-forward activation of MAPK induces separable stem-like and mesenchymal programs","volume":"21","author":"Polak","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.114933_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/ERC-11-0326","article-title":"Oncostatin M suppresses oestrogen receptor-alpha expression and is associated with poor outcome in human breast cancer","volume":"19","author":"West","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.intimp.2025.114933_bb0175","first-page":"8","article-title":"Machine learning applications in cancer prognosis and prediction, Comput Struct","volume":"13","author":"Kourou","year":"2015","journal-title":"Biotechnol. J."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925009233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925009233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:49:51Z","timestamp":1762552191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925009233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"alternative-id":["S1567576925009233"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114933","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics identifies OSM-OSMR as a key receptor-ligand in the tumor environment of endometrial adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114933"}}